Advent-Harrington Impact Fund LP
- Fund Information and Directors
| Advent-Harrington Impact Fund LP |
| Firm |
Advent Life Sciences LLP
|
| Fund # | 805-3761935108 |
| CIK # | 0001827544 |
| Sale | 2020-11-05
($41.6 M Sold)
|
| Fund | Venture Capital Fund |
| Phone | 4402079322100 |
| Address | 158160 North Gower Street
London, United Kingdom NW1 2ND |
| Source |
[EDGAR]
[IAPD]
|
| Fund AUM and Sold ($M) |
|
|
| Fund Details |
| Director | Advent Life Sciences LLP |
| Custodian | |
| Auditor | KPMG |
| Marketer | |
| Broker | |
| Jurisdiction | |
| Form D Offering |
| Filed | 2020-11-06 (D) |
| Exemption | 506(b), 3(c), 3(c)(7) |
| Remaining | Indefinite |
| Duration | One year or less |
| Commission | $208,125 |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
| Kaasim Mahmood |
Executive Officer |
|
| Advent Life Sciences LLP |
Executive Officer |
|
| Shahzad Malik |
Executive Officer |
|
| Rajesh Parekh |
Executive Officer |
|
| ALS III GP LLP |
Executive Officer |
|
| ALS III Carry and Co-Invest LP |
Executive Officer |
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 212438309, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
315987386